Intrinsically Disordered Protein Micelles as Vehicles for Convection-Enhanced Drug Delivery to Glioblastoma Multiforme. 2022

Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
Department of Chemistry, University of California, Berkeley, California 94720, United States.

Lipid and micelle-based nanocarriers have been explored for anticancer drug delivery to improve accumulation and uptake in tumor tissue. As an experimental opportunity in this area, our lab has developed a protein-based micelle nanocarrier consisting of a hydrophilic intrinsically disordered protein (IDP) domain bound to a hydrophobic tail, termed IDP-2Yx2A. This construct can be used to encapsulate hydrophobic chemotherapeutics that would otherwise be too insoluble in water to be administered. In this study, we evaluate the in vivo efficacy of IDP-2Yx2A by delivering a highly potent but water-insoluble cancer drug, SN38, into glioblastoma multiforme (GBM) tumors via convection-enhanced delivery (CED). The protein carriers alone are shown to elicit minimal toxicity effects in mice; furthermore, they can encapsulate and deliver concentrations of SN38 that would otherwise be lethal without the carriers. CED administration of these drug-loaded micelles into mice bearing U251-MG GBM xenografts resulted in slowed tumor growth and significant increases in median survival times compared to nonencapsulated SN38 and PBS controls.

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018481 Convection Transmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed)
D064267 Intrinsically Disordered Proteins Functional proteins that do not have unique, stable, folded, three-dimensional native structures or that possess non-ordered regions under physiological conditions. They are characterized by extraordinary structural flexibility and plasticity, which enable them to adopt different conformations in response to different stimuli or different interactions. Intrinsically Disordered Protein,Natively Unfolded Protein,Unstructured Protein,Natively Unfolded Proteins,Unstructured Proteins,Disordered Protein, Intrinsically,Protein, Intrinsically Disordered,Protein, Natively Unfolded,Protein, Unstructured,Unfolded Protein, Natively

Related Publications

Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
November 2015, Molecular bioSystems,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
January 2014, CNS oncology,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
February 2021, Journal of neuro-oncology,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
December 2020, Drug delivery and translational research,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
December 2018, Nanomaterials (Basel, Switzerland),
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
March 2015, Neuro-oncology,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
January 2015, Surgical neurology international,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
January 2015, CNS oncology,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
May 2023, Bioengineering & translational medicine,
Jamie M Gleason, and Sarah H Klass, and Paul Huang, and Tomoko Ozawa, and Raquel A Santos, and Miko M Fogarty, and David R Raleigh, and Mitchel S Berger, and Matthew B Francis
October 2012, International journal of pharmaceutics,
Copied contents to your clipboard!